15020-1 |
Amylase.P1/Amylase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Amylase.P1/Amylase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15020-1 |
|
|
|
|
Observation |
|
|
|
0 |
Amylase P1 CFr SerPl |
|
|
|
Y |
|
Alpha amylase; Ams; Amyl; Amylase P1; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15021-9 |
Amylase.P2/Amylase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Amylase.P2/Amylase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15021-9 |
|
|
|
|
Observation |
|
|
|
0 |
Amylase P2 CFr SerPl |
|
|
|
Y |
|
Alpha amylase; Ams; Amyl; Amylase P2; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15022-7 |
Amylase.P3/Amylase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Amylase.P3/Amylase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15022-7 |
|
|
|
|
Observation |
|
|
|
0 |
Amylase P3 CFr SerPl |
|
|
|
Y |
|
Alpha amylase; Ams; Amyl; Amylase P3; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15023-5 |
Amylase.S1/Amylase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Amylase S1/Amylase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15023-5 |
|
|
|
|
Observation |
|
|
|
0 |
Amylase S1 CFr SerPl |
|
|
|
Y |
|
Alpha amylase; Ams; Amyl; Amylase S1; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15024-3 |
Amylase.S2/Amylase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Amylase S2/Amylase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15024-3 |
|
|
|
|
Observation |
|
|
|
0 |
Amylase S2 CFr SerPl |
|
|
|
Y |
|
Alpha amylase; Ams; Amyl; Amylase S2; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15025-0 |
Amylase.S3/Amylase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Amylase S3/Amylase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15025-0 |
|
|
|
|
Observation |
|
|
|
0 |
Amylase S3 CFr SerPl |
|
|
|
Y |
|
Alpha amylase; Ams; Amyl; Amylase S3; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15026-8 |
Androstanediol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Androstanediol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
15026-8 |
|
|
|
|
Both |
|
|
|
0 |
Androstanediol SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.4 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
15027-6 |
Androstenedione |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Androstenedione [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
15027-6 |
|
|
|
|
Both |
|
|
|
0 |
Androst Ur-sCnc |
|
|
|
Y |
|
Chemistry; gamma-4-Androstenedione; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
15028-4 |
Androstenedione |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Androstenedione [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
15028-4 |
|
|
|
|
Both |
|
|
|
0 |
Androst 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; gamma-4-Androstenedione; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15029-2 |
Androsterone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Androsterone [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
15029-2 |
|
|
|
|
Both |
|
|
|
0 |
Androsterone SerPl-sCnc |
|
|
|
Y |
|
Androster; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.4 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
1503-2 |
Glucose^1H post 100 g glucose PO |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1503-2 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 1h p 100 g Glc PO Ur-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p 100 g Glc PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15030-0 |
Androsterone |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Androsterone [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
15030-0 |
|
|
|
|
Both |
|
|
|
0 |
Androsterone 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Androster; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15031-8 |
Angiotensin I |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Angiotensin I [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
15031-8 |
|
|
|
|
Both |
|
|
|
0 |
Angiotensin I Plas-sCnc |
|
|
|
Y |
|
AGT; AI; Angiotensin 1; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
15032-6 |
Angiotensin II |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Angiotensin II [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
15032-6 |
|
|
|
|
Both |
|
|
|
0 |
Angiotensin II Plas-sCnc |
|
|
|
Y |
|
2; AGT; Angiotensin 2; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.42 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
15033-4 |
Ascorbate |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Ascorbate [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
15033-4 |
|
|
|
|
Both |
|
|
|
0 |
Vit C 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Ascorbic acid; c702; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn; Vit C; Vitamin C |
2.4 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15034-2 |
Bromide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bromide [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15034-2 |
|
|
|
|
Both |
|
|
|
0 |
Bromide SerPl-sCnc |
|
|
|
Y |
|
BR; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
15035-9 |
Calcitonin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcitonin [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
15035-9 |
|
|
|
|
Both |
|
|
|
0 |
Calcit SerPl-sCnc |
|
|
|
Y |
|
Chemistry; CT; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Thyrocalcitonin; Tumor marker |
2.73 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
15036-7 |
Catecholamines |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Catecholamines [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
15036-7 |
|
|
|
|
Both |
|
|
|
0 |
Catechols 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.5 |
1.0k |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
15037-5 |
Chymotrypsin |
SCnt |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Chymotrypsin [Moles/mass] in Stool |
|
MIN |
DefinitionDescription |
|
|
mol/kg |
|
|
|
|
|
|
CHEM |
|
15037-5 |
|
|
|
|
Both |
|
|
|
0 |
Chymotryp Stl-sCnt |
|
|
|
Y |
|
Bowel movement; Chemistry; Chymotrypsine; Faecal; Faeces; Fecal; Feces; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Content |
2.42 |
1.0k |
|
|
|
|
|
|
|
mol/kg |
|
|
|
0 |
15038-3 |
Citrate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Citrate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
15038-3 |
|
|
|
|
Both |
|
|
|
0 |
Citrate SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Citric acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
15039-1 |
Cobalamin |
SCnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cobalamin [Molecules/volume] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15039-1 |
|
|
|
|
|
|
|
|
0 |
Deprecated Cobalamin Ser-sCnc |
|
|
|
Y |
|
Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration |
2.36 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
1504-0 |
Glucose^1H post 50 g glucose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL.ROUTINE |
|
1504-0 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 1h p 50 g Glc PO SerPl-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p 50 g Glc PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 50 g Glc; p 50 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
Changed Class from "CHAL" to "CHAL.ROUTINE" |
171 |
15040-9 |
Coproporphyrin |
SRat |
Stool |
24H |
Qn |
|
|
ACTIVE |
Coproporphyrin [Moles/time] in 24 hour Stool |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
15040-9 |
|
|
|
|
Observation |
|
|
|
0 |
Copro 24h Stl-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Bowel movement; Chemistry; Copro; Coproporph; Coproporphyrins; Faecal; Faeces; Fecal; Feces; Hematology; Heme; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15041-7 |
Coproporphyrin |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Coproporphyrin [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
15041-7 |
|
|
|
|
Observation |
|
|
|
0 |
Copro 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Copro; Coproporph; Coproporphyrins; Hematology; Heme; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
15042-5 |
Corticotropin |
ACnc |
Ser |
Pt |
Qn |
|
|
DISCOURAGED |
Corticotropin [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15042-5 |
|
|
|
|
Both |
|
|
|
0 |
ACTH Ser-aCnc |
|
|
|
Y |
|
ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Arbitrary concentration; c206; c74; Chemistry; Cortrosyn; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Serum; SR; Tumor marker |
2.69 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |